flanders.bio is an independent life sciences cluster organisation based in Flanders, Belgium

flanders.bio is a dynamic, member driven organisation with currently more than 350 members from Belgium and abroad. We help our members to create value by organising Networking and Training Activities, supporting Internationalisation, providing Services and building Expertise. flanders.bio and its members want to be the proud advocates of a reputable global-impact ecosystem in life sciences.

News from flanders.bio and its members

Mithra Demonstrates Further Estetrol’s Unique Profile at the Annual Meeting of the Endocrine Society

Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health has presented the results of a new study on Estetrol (E4) at the 101st Annual Meeting of the Endocrine Society (ENDO 2019) held from March 23 to 26 in New Orleans (U.S.)

Plant immunity cut to size

An international team based in Ghent, Belgium (VIB-UGent Center for Plant Systems Biology) and Basel, Switzerland (University of Basel) found a link between a class of enzymes and immune signals that is rapidly triggered upon physical damage in plants. This new discovery will increase our understanding of the plant immune system and might be exploited to improve crop health and yield in the future.

The Innovative Medicines Initiative launches a public-private coordination and support action

Today, the members of the NEURONET project announced the start of a new collaborative pan-European coordination and support initiative for the Innovative Medicines Initiative (IMI) projects of the Neurodegenerative Disorders (ND) portfolio. CMAST - a leading consultancy and project management company in life sciences – is also involved in this project, in support of Janssen Pharmaceutica.

Galapagos increases share capital through warrant exercises

Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises.

flanders.bio events, trainings & international missions

Strategic Partners